Biden Deploys Phase 1 Fednow Digital Currency Discover how to legally "opt-out" of the digital dollar today. No matter what they say, it's not something that will help you. If you don't take the action steps shown below…

ACW Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.81%

Insider Buying (Last 12 Months): A$0.00

Insider Selling (Last 12 Months): A$0.00

Actinogen Medical Insider Trading History Chart

Actinogen Medical Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

Actinogen Medical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
4/4/2024	Malcolm McComas	Insider	Expiry	3,000,000	A$0.03	A$87,000.00
12/1/2023	Nicki Vasquez	Insider	Issued	5,500,000	A$0.03	A$170,500.00
11/27/2023	Geoffrey Brooke	Insider	Expiry	4,900,000	A$0.02	A$112,700.00
9/11/2023	Geoffrey Brooke	Insider	Issued	474,058	A$0.03	A$11,851.45
11/11/2022	George Morstyn	Insider	Exercise	1,500,000	A$0.10	A$150,000.00
11/3/2022	Steven Gourlay	Insider	Buy	750,000	A$0.13	A$93,750.00
5/12/2022	Steven Gourlay	Insider	Buy	2,000,000	A$0.06	A$128,000.00
4/6/2022	Steven Gourlay	Insider	Issued	797,222	A$0.14	A$107,624.97
12/20/2021	George Morstyn	Insider	Issued	222,223	A$0.14	A$30,000.11
11/18/2021	Geoffrey Brooke	Insider	Issued	2,500,000	A$0.20	A$500,000.00

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here

SEC Filings (Institutional Ownership Changes) for Actinogen Medical (ASX:ACW)

10.61% of Actinogen Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, depression with cognitive impairment, Alzheimer's disease, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

275,000 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

8.76%

Beta

2.28

Who are the company insiders with the largest holdings of Actinogen Medical?: Actinogen Medical's top insider shareholders include:
Geoffrey Brooke (Insider)
George Morstyn (Insider)
Malcolm McComas (Insider)
Nicki Vasquez (Insider)
Steven Gourlay (Insider)
Learn More about top insider investors at Actinogen Medical.

Your Money is Not Safe

From American Alternative | Ad

CLICK HERE TO GET YOUR GUIDE NOW